← FDA DRUG APPROVALS

FDA ANDA · ANDA060075

PFIZERPEN G

Sponsor: PFIZER

APPLICATION
ANDA060075
TYPE
ANDA
ORIGINAL APPROVAL
1948-03-02
LATEST ACTION
1948-03-02
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PFIZERPEN GDiscontinued
PENICILLIN G POTASSIUM 400,000 UNITS · TABLET · ORAL
PFIZERPEN GDiscontinued
PENICILLIN G POTASSIUM 200,000 UNITS · TABLET · ORAL
PFIZERPEN GDiscontinued
PENICILLIN G POTASSIUM 50,000 UNITS · TABLET · ORAL
PFIZERPEN GDiscontinued
PENICILLIN G POTASSIUM 800,000 UNITS · TABLET · ORAL
PFIZERPEN GDiscontinued
PENICILLIN G POTASSIUM 250,000 UNITS · TABLET · ORAL
PFIZERPEN GDiscontinued
PENICILLIN G POTASSIUM 100,000 UNITS · TABLET · ORAL

Approval history

1948-03-02OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →